Cargando…
Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307762/ https://www.ncbi.nlm.nih.gov/pubmed/37380873 http://dx.doi.org/10.1186/s13613-023-01158-1 |
| _version_ | 1785066103573053440 |
|---|---|
| author | Helms, Julie Poissy, Julien Dequin, Pierre-François Timsit, Jean-François |
| author_facet | Helms, Julie Poissy, Julien Dequin, Pierre-François Timsit, Jean-François |
| author_sort | Helms, Julie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10307762 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103077622023-06-30 Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option Helms, Julie Poissy, Julien Dequin, Pierre-François Timsit, Jean-François Ann Intensive Care Letter to the Editor Springer International Publishing 2023-06-28 /pmc/articles/PMC10307762/ /pubmed/37380873 http://dx.doi.org/10.1186/s13613-023-01158-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Helms, Julie Poissy, Julien Dequin, Pierre-François Timsit, Jean-François Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title | Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title_full | Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title_fullStr | Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title_full_unstemmed | Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title_short | Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| title_sort | treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307762/ https://www.ncbi.nlm.nih.gov/pubmed/37380873 http://dx.doi.org/10.1186/s13613-023-01158-1 |
| work_keys_str_mv | AT helmsjulie treatmentofimmunothrombosisdysregulationhighdosecorticosteroidsisnotthegoodoption AT poissyjulien treatmentofimmunothrombosisdysregulationhighdosecorticosteroidsisnotthegoodoption AT dequinpierrefrancois treatmentofimmunothrombosisdysregulationhighdosecorticosteroidsisnotthegoodoption AT timsitjeanfrancois treatmentofimmunothrombosisdysregulationhighdosecorticosteroidsisnotthegoodoption |